Sign In
Buy NVAX
$10.19
-0.0100 (-0.0980%)
At Close: Jun 04, 2026
Novavax Is Betting Its COVID Vaccine Will Win U.S. Authorization. Should You?
09:55am, Tuesday, 15'th Mar 2022 The Motley Fool
The odds that Novavax wins U.S. Emergency Use Authorization for its vaccine should be pretty good.
Vaccine maker stocks rise as China battles worst Covid outbreak since 2020
07:21pm, Monday, 14'th Mar 2022 CNBC
Shares of Moderna, BioNTech, Pfizer, Johnson & Johnson and Novavax rose on Monday as China battles its worst Covid outbreak in two years.
Why BioNTech, Dynavax, Novavax, and Pfizer Stocks Are Jumping Today
04:24pm, Monday, 14'th Mar 2022 The Motley Fool
The broader stock market bounce and news from China are fueling gains for all four vaccine stocks.
Why BioNTech, Dynavax, Novavax, and Pfizer Stocks Are Jumping Today
04:24pm, Monday, 14'th Mar 2022 The Motley Fool
The broader stock market bounce and news from China are fueling gains for all four vaccine stocks.
Here''s Why Pfizer And Novavax Shares Are Rising On Monday
03:18pm, Monday, 14'th Mar 2022 Benzinga
Pfizer Inc. (NYSE: PFE ) and Novavax, Inc. (NASDAQ: NVAX ) shares are trading higher by 4.3% at $52.42 and 9.6% at $80.05 respectively. Strength is possibly due to a spike in COVID-19 cases in China, which could lift vaccine sector sentiment. A spike … Full story available on Benzinga.com
Novavax''s Covid-19 vaccine roll-out in EU off to slow start — data
09:15am, Monday, 14'th Mar 2022 The Edge Markets
Demand for the Covid-19 vaccine produced by US biotech firm Novavax has been underwhelming in the European Union''s main countries in the early roll-out, so far undermining hopes that it could convince vaccine sceptics to get a shot.
Novavax''s COVID vaccine rollout in EU off to a slow start -data | Health
08:55am, Monday, 14'th Mar 2022 Devdiscourse
But initial data on Nuvaxovid''s rollout show that it has had a small impact on vaccination campaigns. In Germany, the EU''s most populous country and home to more than 10 million unvaccinated adults, only about 38,000 Novavax doses have been administered since the start of the rollout on Feb. 24, according to data from the Robert Koch Institute.
Novavax''s Covid-19 vaccine rollout in EU off to a slow start: Data
08:21am, Monday, 14'th Mar 2022 The Straits Times
March 14, 2022 4:21 PM Novavax was expected to persuade some sceptics because it is based on a more conventional technology.
Novavax’s Covid vaccine rollout in EU off to a slow start, says data
08:20am, Monday, 14'th Mar 2022 Malay Mail
BRUSSELS, March 14 — Demand for the Covid-19 vaccine produced by US biotech firm Novavax has been underwhelming in the European Union’s main countries in the early rollout, so far undermining hopes that it could convince vaccine sceptics…
3 Sizzling Growth Stocks to Buy During a Biden Bear Market
09:51am, Sunday, 13'th Mar 2022 The Motley Fool
A tumbling market is your cue to buy into these highly innovative companies.
Is It Too Late to Buy BioNTech Stock?
04:45pm, Saturday, 12'th Mar 2022 The Motley Fool
The market has probably priced in the impacts of its biggest source of revenue.
Biden's COVID program faces uncertainty after funding dropped from bill, and Moderna to trial omicron-specific booster
12:11pm, Friday, 11'th Mar 2022 MarketWatch
President Joe Biden's COVID-19 program faced some uncertainty Thursday, after U.S. lawmakers passed a massive new bill that would fund the federal government for the remainder of the fiscal year, as w
3 Stocks That Can Turn $10,000 Into $50,000 by 2025
11:30am, Friday, 11'th Mar 2022 The Motley Fool
Revenue is ready to soar at these companies.
Moderna and Other Vaccine Stocks Finally Rallied Wednesday. Buyers May Be Back.
03:02pm, Thursday, 10'th Mar 2022 Barron''s
After months of poor performance, Moderna, BioNTech, and Novavax surged Wednesday. Bears now "are less negative" on Moderna, says one analyst.
Is Novavax's Biggest Catalyst Ever Just Ahead?
03:00pm, Thursday, 10'th Mar 2022 The Motley Fool
It could open the door to major gains in the long term.
